A serum metabolomics study of patients with nAMD in response to anti-VEGF therapy

Intravitreal injection of anti-vascular endothelial growth factor (anti-VEGF) is the current standard of treatment for choroidal neovascularization (CNV) secondary to neovascular age-related macular degeneration (nAMD), but there are no diagnostic tools to predict response of these therapies. We hyp...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Yan, Teo, Yi Chong Kelvin, Beuerman, Roger W., Wong, Tien Yin, Zhou, Lei, Cheung, Chui Ming Gemmy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6987119/
https://www.ncbi.nlm.nih.gov/pubmed/31992792
http://dx.doi.org/10.1038/s41598-020-58346-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6987119/
https://www.ncbi.nlm.nih.gov/pubmed/31992792
http://dx.doi.org/10.1038/s41598-020-58346-3

Ejemplares similares